Published in World J Gastroenterol on May 14, 2009
Current concepts on gastric carcinoid tumors. Gastroenterol Res Pract (2012) 1.04
Long-term follow up of endoscopic resection for type 3 gastric NET. World J Gastroenterol (2013) 0.94
Endoscopic diagnosis and management of type I neuroendocrine tumors. World J Gastrointest Endosc (2015) 0.79
Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1. Cancers (Basel) (2012) 0.79
Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol (2016) 0.75
Biomagnetic techniques for evaluating gastric emptying, peristaltic contraction and transit time. World J Gastrointest Pathophysiol (2011) 0.75
A 5-decade analysis of 13,715 carcinoid tumors. Cancer (2003) 12.78
Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol (2008) 7.65
Current status of gastrointestinal carcinoids. Gastroenterology (2005) 4.26
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology (1993) 4.04
Epidemiology of stomach cancer. Methods Mol Biol (2009) 3.72
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer (2008) 2.16
Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients. Cancer (1994) 2.15
Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg (2005) 1.99
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst (2008) 1.71
A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol (2004) 1.67
Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol (1995) 1.59
Review article: Pathogenesis and management of gastric carcinoid tumours. Aliment Pharmacol Ther (2006) 1.57
Carcinoid tumors of the stomach. Surg Oncol (2003) 1.47
[Gastric carcinoid tumours. Is there a place for antrectomy?]. Ann Chir (2005) 1.46
Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer (1991) 1.42
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology (2007) 1.40
Prognosis of gastric carcinoid tumours. Digestion (1995) 1.23
Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology (1992) 1.22
Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis. Gastric Cancer (2005) 1.15
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Invest (2008) 1.14
Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol (2009) 1.12
Well-differentiated gastric tumors/carcinomas. Neuroendocrinology (2007) 1.06
Molecular genetics of neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab (2007) 1.03
Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor. Gastroenterology (1998) 1.02
Gastric carcinoids: a temporal increase with proton pump introduction. Surg Endosc (2005) 1.01
Biology and management of gastric carcinoid tumours: a review. Eur J Surg (2002) 0.99
Management of patients with Zollinger-Ellison syndrome. Annu Rev Med (1995) 0.98
Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med (2000) 0.97
Presentation, treatment, and outcome of type 1 gastric carcinoid tumors. J Surg Oncol (2006) 0.97
A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab (2008) 0.93
Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. Eur J Endocrinol (2005) 0.91
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs. Endocr Relat Cancer (2008) 0.91
Treatment of ECL cell carcinoids with octreotide LAR. Scand J Gastroenterol (2004) 0.91
Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor. Am J Physiol Gastrointest Liver Physiol (2008) 0.90
Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue. Eur J Gastroenterol Hepatol (2007) 0.89
A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol (2008) 0.87
Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol (2005) 0.87
Oxyntic endocrine cells of hypergastrinaemic patients. Differential response to antrectomy or octreotide. Gut (1996) 0.86
Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours. Dig Liver Dis (2007) 0.85
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours. Eur J Endocrinol (2008) 0.85
Treatment of gastric carcinoids. Curr Treat Options Gastroenterol (2007) 0.85
Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. Am J Surg Pathol (1996) 0.83
Gastric carcinoid. Curr Opin Oncol (2005) 0.83
Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med (2002) 10.78
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut (2007) 3.58
Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol (2012) 2.92
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol (2006) 2.67
Severe liver fibrosis or cirrhosis: accuracy of US for detection--analysis of 300 cases. Radiology (2003) 2.51
Plasma chromogranin a in patients with inflammatory bowel disease. Inflamm Bowel Dis (2009) 2.37
Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors. Am J Gastroenterol (2010) 1.59
Defensive medicine practices among gastroenterologists in Lombardy: between lawsuits and the economic crisis. Dig Liver Dis (2013) 1.58
Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency. Haematologica (2006) 1.51
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors. Hepatology (2010) 1.50
Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol (2008) 1.48
Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B. Eur J Gastroenterol Hepatol (2010) 1.47
Evaluation of hands-on training in colonoscopy: is a computer-based simulator useful? Dig Liver Dis (2012) 1.38
Role of US in detection of Crohn disease: meta-analysis. Radiology (2005) 1.29
Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood (2002) 1.22
Nutritional deficiencies in inflammatory bowel disease: therapeutic approaches. Clin Nutr (2013) 1.18
Small bowel capsule endoscopy in clinical practice: a multicenter 7-year survey. Eur J Gastroenterol Hepatol (2010) 1.13
Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab (2003) 1.09
Alpha-fetoprotein and hepatocellular carcinoma. Am J Gastroenterol (2006) 1.09
Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia. Dig Dis Sci (2011) 1.06
High tumor necrosis factor-alpha [corrected] levels in cerebrospinal fluid of cobalamin-deficient patients. Ann Neurol (2004) 1.04
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). Dig Liver Dis (2011) 1.03
The architecture of diagnostic research: from bench to bedside--research guidelines using liver stiffness as an example. Hepatology (2014) 0.99
Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol (2010) 0.96
Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res (2009) 0.95
Computer-assisted evaluation of perianal fistula activity by means of anal ultrasound in patients with Crohn's disease. Am J Gastroenterol (2006) 0.94
Tissue transglutaminase antibodies in patients with end-stage heart failure. Am J Gastroenterol (2002) 0.93
Epstein-Barr virus-associated lymphoma in Crohn's disease. Inflamm Bowel Dis (2004) 0.93
Effects of modified sham feeding on ghrelin levels in healthy human subjects. J Clin Endocrinol Metab (2004) 0.92
Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C. World J Gastroenterol (2005) 0.91
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis. J Hepatol (2012) 0.90
Circulating ghrelin levels in celiac patients. Am J Gastroenterol (2003) 0.90
Assessing the activity of perianal Crohn's disease: comparison of clinical indices and computer-assisted anal ultrasound. Inflamm Bowel Dis (2009) 0.90
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy. Inflamm Bowel Dis (2013) 0.90
Oxidative stress-mediated down-regulation of rat hydroxyacid oxidase 1, a liver-specific peroxisomal enzyme. Hepatology (2003) 0.89
A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validation. J Hepatol (2008) 0.88
New insights into the pathophysiology of cobalamin deficiency. Trends Mol Med (2006) 0.87
Cerebellar degeneration and hearing loss in a patient with idiopathic myenteric ganglionitis. Eur J Gastroenterol Hepatol (2005) 0.86
A follow-up study of patients with Zollinger-Ellison syndrome in the period 1966-2002: effects of surgical and medical treatments on long-term survival. J Clin Gastroenterol (2005) 0.85
Adaptive changes of duodenal iron transport proteins in celiac disease. Physiol Genomics (2004) 0.84
The Role of Ultrasound Elasticity Imaging in Predicting Ileal Fibrosis in Crohn's Disease Patients. Inflamm Bowel Dis (2015) 0.84
Treatment of liver metastases in patients with digestive neuroendocrine tumors. J Gastrointest Surg (2012) 0.84
Accuracy of ultrasonography in predicting celiac disease. Arch Intern Med (2004) 0.84
Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution. Neuroendocrinology (2014) 0.83
Antiendomysial antibodies in patients with end-stage heart failure. Am J Gastroenterol (2002) 0.83
Transferrin receptor 1 (TfR1) and putative stimulator of Fe transport (SFT) expression in iron deficiency and overload: an overview. Blood Cells Mol Dis (2003) 0.82
Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature. Eur J Gastroenterol Hepatol (2012) 0.81
Management of warfarin-associated coagulopathy in patients with acute gastrointestinal bleeding: a cross-sectional physician survey of current practice. Dig Liver Dis (2010) 0.81
microRNA profiles in coeliac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts. Clin Sci (Lond) (2014) 0.81
Peripheral blood count abnormalities among patients with hepatitis C in the United States. Hepatology (2002) 0.80
Severe chronic diarrhea and maculopapular rash: a case report. World J Gastroenterol (2011) 0.80
Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence? Scand J Gastroenterol (2015) 0.79
Unsatisfactory quality of hepatological information on the internet. J Hepatol (2004) 0.78
Primary sclerosing cholangitis associated with inflammatory bowel disease: an update. Eur J Gastroenterol Hepatol (2016) 0.78
Can we improve the detection rate and interobserver agreement in capsule endoscopy? Dig Liver Dis (2012) 0.78
Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology (2005) 0.78
Gallstones and liver disease: an overview. J Gastrointestin Liver Dis (2011) 0.77
Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews. J Gastroenterol Hepatol (2011) 0.77
Gluten-free diet or alternative therapy: a survey on what parents of celiac children want. Int J Food Sci Nutr (2015) 0.77
Noncoeliac gluten sensitivity: a diagnostic dilemma. Curr Opin Clin Nutr Metab Care (2015) 0.77
Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients. J Clin Gastroenterol (2008) 0.77
The role of ultrasonography in patients with celiac disease. World J Gastroenterol (2006) 0.77
Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease. Scand J Gastroenterol (2006) 0.77
Celiac Disease and Drug-Based Therapies: Inquiry into Patients Demands. Digestion (2016) 0.77
Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study. Eur J Endocrinol (2013) 0.77
Extracellular matrix proteins and displacement of cultured fibroblasts from duodenal biopsies in celiac patients and controls. J Transl Med (2013) 0.77
"Pseudotumoral" hepatic areas in acute alcoholic hepatitis: a computed tomography and histological study. Am J Gastroenterol (2005) 0.77
Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours. Dig Liver Dis (2010) 0.76
Transient elastography in the assessment of liver fibrosis in adult thalassemia patients. Am J Hematol (2010) 0.76
Bleeding after sphincterotomy in liver transplanted patients with biliary complications. Eur J Gastroenterol Hepatol (2011) 0.76
Transient elastography in patients with celiac disease: a noninvasive method to detect liver involvement associated with celiac disease. Scand J Gastroenterol (2012) 0.76
An esophageal gastrointestinal stromal tumor in a patient with MEN1-related pancreatic gastrinoma: an unusual association and review of the literature. J Cancer Res Ther (2014) 0.76
Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions. J Clin Neurosci (2012) 0.76
Neuromuscular alterations in the dilated ileum of an adult patient with segmental lymphangiectasia. Eur J Gastroenterol Hepatol (2008) 0.75
B-type natriuretic peptide in heart failure. N Engl J Med (2002) 0.75
Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature. BMC Gastroenterol (2014) 0.75
The role of dietary supplements in inflammatory bowel disease: a systematic review. Eur J Gastroenterol Hepatol (2016) 0.75
"Pseudotumoral" hepatic pattern in acute alcoholic hepatitis: a case report. World J Gastroenterol (2009) 0.75
Re: Oxentenko et al.--Endoscopic markers in celiac disease. Am J Gastroenterol (2002) 0.75
Celiac sprue. N Engl J Med (2002) 0.75
Currently neglected, physical examination maintains its clinical relevance. Intern Emerg Med (2014) 0.75
Double balloon extraction in choledocholitiasis. Eur J Gastroenterol Hepatol (2008) 0.75